JP2006517217A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006517217A5 JP2006517217A5 JP2006501782A JP2006501782A JP2006517217A5 JP 2006517217 A5 JP2006517217 A5 JP 2006517217A5 JP 2006501782 A JP2006501782 A JP 2006501782A JP 2006501782 A JP2006501782 A JP 2006501782A JP 2006517217 A5 JP2006517217 A5 JP 2006517217A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- use according
- compound
- calcineurin inhibitor
- corticoid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 C*C(C(N(C)C(*C)C(NC(C)C(NC(C)C(N(C)C(*)C(N(C)C(*C)C(N(C)C(C(C)(C)C)C(N(C)C(C(C)(CCC=CC)O)C(NC(*)C(N(C)CC(N(C)C1*C)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)NC1=O Chemical compound C*C(C(N(C)C(*C)C(NC(C)C(NC(C)C(N(C)C(*)C(N(C)C(*C)C(N(C)C(C(C)(C)C)C(N(C)C(C(C)(CCC=CC)O)C(NC(*)C(N(C)CC(N(C)C1*C)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)NC1=O 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0302991A GB0302991D0 (en) | 2003-02-10 | 2003-02-10 | Organic compounds |
| GB0316436A GB0316436D0 (en) | 2003-07-14 | 2003-07-14 | Organic compounds |
| PCT/EP2004/001179 WO2004069267A1 (en) | 2003-02-10 | 2004-02-09 | Pharmaceutical combinations comprising corticoids and immunosuppressants for treating corticoid- and/or calcineurin inhibitors-resistant diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006517217A JP2006517217A (ja) | 2006-07-20 |
| JP2006517217A5 true JP2006517217A5 (https=) | 2007-03-15 |
Family
ID=32852416
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006501782A Pending JP2006517217A (ja) | 2003-02-10 | 2004-02-09 | コルチコイドおよび／またはカルシニューリン阻害剤耐性疾患を処置するための、コルチコイドおよび免疫抑制剤を含んでなる医薬組合せ剤 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20060083754A1 (https=) |
| EP (1) | EP1594522A1 (https=) |
| JP (1) | JP2006517217A (https=) |
| BR (1) | BRPI0407350A (https=) |
| CA (1) | CA2513731A1 (https=) |
| WO (1) | WO2004069267A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1941911A4 (en) * | 2005-10-28 | 2011-01-12 | Kowa Co | METHOD FOR THE PREVENTION AND / OR TREATMENT OF RHEUMATOID ARTHRITIS |
| WO2007056457A2 (en) * | 2005-11-09 | 2007-05-18 | Combinatorx, Incorporated | Methods, compositions, and kits for the treatment of medical conditions |
| WO2011054399A1 (en) * | 2009-11-06 | 2011-05-12 | Avail Gmbh | Improvement of the glucocorticoid receptor function in asthma |
| WO2022242741A1 (en) * | 2021-05-20 | 2022-11-24 | Chengdu Anticancer Bioscience, Ltd. | Methods comprising administration of a glucocorticoid receptor agonist and an inhibitor of calcineurin |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5540931A (en) * | 1989-03-03 | 1996-07-30 | Charles W. Hewitt | Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants |
| US4996193A (en) * | 1989-03-03 | 1991-02-26 | The Regents Of The University Of California | Combined topical and systemic method of administration of cyclosporine |
| DK0427680T3 (da) * | 1989-11-09 | 1995-12-18 | Sandoz Ltd | Heteroatom-holdige cykliske forbindelser |
| US5215965A (en) * | 1990-10-02 | 1993-06-01 | John Lezdey | Treatment of inflammation |
| AU8910891A (en) * | 1990-11-20 | 1992-06-11 | National Heart & Lung Institute, The | Treatment of lung diseases |
| JP2001510485A (ja) * | 1999-03-01 | 2001-07-31 | シェーリング コーポレイション | アトピー性皮膚炎、血管性浮腫および他の障害を抗ヒスタミン薬およびグルココルチコイドを用いて処置するための組成物および方法 |
-
2004
- 2004-02-09 WO PCT/EP2004/001179 patent/WO2004069267A1/en not_active Ceased
- 2004-02-09 US US10/544,918 patent/US20060083754A1/en not_active Abandoned
- 2004-02-09 EP EP04709211A patent/EP1594522A1/en not_active Withdrawn
- 2004-02-09 CA CA002513731A patent/CA2513731A1/en not_active Abandoned
- 2004-02-09 JP JP2006501782A patent/JP2006517217A/ja active Pending
- 2004-02-09 BR BR0407350-9A patent/BRPI0407350A/pt not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010510210A5 (https=) | ||
| CN1039329C (zh) | 制备甾酯类化合物的方法 | |
| Stojakovic et al. | Atorvastatin in patients with primary biliary cirrhosis and incomplete biochemical response to ursodeoxycholic acid | |
| US5807834A (en) | Combination of a cholesterol absorption inhibitor and a cholesterol synthesis inhibitor | |
| US5981517A (en) | Androstene derivatives | |
| JP2006508138A (ja) | アレルギー性鼻炎を処置するための抗アレルギー剤およびステロイドの使用 | |
| RU2009107537A (ru) | Новые стероидные соединения, обладающие повышенной растворимостью в воде и устойчивостью к метаболизму, и способы их приготовления | |
| WO2009085880A2 (en) | C-21 thioethers as glucocorticoid receptor agonists | |
| JP2006512313A5 (https=) | ||
| JP2015038079A (ja) | ホスホジエステラーゼ阻害剤としての安息香酸（１−フェニル−２−ピリジン−４−イル）エチルエステル | |
| RU2648475C2 (ru) | Терапевтическое применение эктоина | |
| CZ304294B6 (cs) | Léčivo a farmaceutická souprava | |
| JP2009542649A5 (https=) | ||
| JP2011506412A5 (https=) | ||
| NO20076319L (no) | Farmasoytiske sammensetninger av et neuroaktivt steroid og anvendelse derav | |
| HRP20100366T1 (hr) | Antagonisti receptora progesterona | |
| RU2015154037A (ru) | Применение антагониста рецептора NK-1 серлопитанта при зуде | |
| CN1064079A (zh) | 新的甾族化合物 | |
| JP2011502174A5 (https=) | ||
| JP2016531895A5 (https=) | ||
| CA2558944A1 (en) | Enhancement of activity and/or duration of action of soft anti-inflammatory steroids for topical or other local application | |
| RU2018103940A (ru) | Фармацевтические композиции, содержащие антагонист интегрина альфа4, для применения в лечении воспалительных состояний глаза | |
| WO2006027377A1 (en) | Ciclesonide and syk inhibitor combination and methods of use thereof | |
| JP2006517217A5 (https=) | ||
| CN1674939A (zh) | 用于治疗呼吸性疾病、过敏性疾病、哮喘和copd的糖皮质激素与磷酸二酯酶－4抑制剂的新组合 |